跳至主要内容
临床试验/NCT06093568
NCT06093568尚未招募不适用

Exploring Engagement Dynamics Among Individuals Impacted by Renal Cell Carcinoma

Power Life Sciences Inc.1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2024年11月最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
500
试验地点
1
主要终点
Number of patients who decide to participate in a renal cell carcinoma clinical study

研究概览

简要总结

The study seeks to delve into the firsthand experiences of patients diagnosed with renal cell carcinoma who partake in a separate clinical study featuring a specific medical intervention. The primary emphasis will be on meticulously tracking the rates of trial completion and withdrawal among these individuals.

By joining this clinical trial, individuals have the unique opportunity to contribute to the betterment of future renal cell carcinoma patients and play an active role in advancing clinical research.

研究设计

研究类型
Observational
观察模型
Case Crossover
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient has been diagnosed with renal cell carcinoma
  • Patient is a minimum of 18 years or older
  • Patient has self-identified as planning to enroll in a clinical study

排除标准

  • Patient does not understand, sign, and return consent form
  • Inability to perform regular electronic reporting
  • Patient is pregnant

结局指标

主要结局

Number of patients who decide to participate in a renal cell carcinoma clinical study

时间窗: 3 months

Rate of patients who remain in renal cell carcinoma clinical trial to trial completion

时间窗: 12 months

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验